|
|
|
|
Small Stocks, Big Money™
|
|
Weekly Newsletter
|
|
|
|
|
|
|
|
Nova Minerals Charts U.S. Redomicile, Targets Full Ownership of Flagship Estelle Project
Nova Minerals (Nasdaq: NVA) unveiled plans to redomicile to the United States by mid-2026 while maintaining its dual Nasdaq and ASX listings, a move expected to unlock broader access to lower-cost U.S. capital and institutional investors. As part of the reorganization, the Company intends to acquire the remaining 15% of the Estelle Gold and Critical Minerals Project, positioning Nova with 100% ownership as it advances one of the largest undeveloped gold and antimony projects in the U.S. toward construction and production.
|
|
|
|
60 Degrees Pharma Expands ARAKODA® Access through GoodRx Partnership
60 Degrees Pharmaceuticals (Nasdaq: SXTP) announced a new partnership with GoodRx to broaden access to ARAKODA®, the only FDA-approved, once-weekly malaria prevention therapy in the U.S. The collaboration, which became effective February 2, extends ARAKODA’s reach to over 70,000 pharmacies nationwide, enhancing patient affordability while supporting wider adoption among travelers to malaria-endemic regions and reinforcing the Company’s commercial growth strategy.
|
|
|
|
|
NioCorp’s Elk Creek Project Aligned with New $12B U.S. Critical Minerals Reserve
NioCorp Developments (Nasdaq: NB) praised the White House and the Export-Import Bank of the United States for launching the proposed $12 billion “Project Vault,” a landmark public-private initiative to establish a U.S. Strategic Critical Minerals Reserve. Backed by $11 billion from EXIM and nearly $1.7 billion from major U.S. manufacturers, the program underscores accelerating federal support for domestic critical minerals production—aligning closely with NioCorp’s Elk Creek Project as the Company advances toward supplying U.S.-sourced niobium, scandium, titanium, and potentially rare earths to strengthen American industrial and national security supply chains.
|
|
|
|
|
|
|
XTI Aerospace Streamlines Portfolio, Divests RTLS Unit to Accelerate Drone and UAS Growth
XTI Aerospace (Nasdaq: XTIA) announced the completed sale of its Inpixon RTLS business for approximately $5.5 million, sharpening the Company’s strategic focus on drones, unmanned aircraft systems, and advanced vertical flight technologies. The divestiture reduces operating complexity and costs while allowing XTI to concentrate capital and leadership on scaling its Drone Nerds platform for enterprise and government customers, supporting the Company’s stated path toward sustainable profitability in 2026.
|
|
|
|
|
Bimergen Energy Targets NYSE American Uplist as It Advances Utility-Scale Battery Storage Platform
Bimergen Energy Corporation (OTCQB: BESS) announced that its common stock and warrants are expected to begin trading on the NYSE American on or about February 11, 2026, marking a key milestone in the Company’s evolution as a utility-scale battery energy storage owner and developer. The anticipated uplisting, alongside a concurrent securities offering following SEC effectiveness of its S-1, is expected to enhance capital markets access, visibility, and liquidity as Bimergen continues to build and operate battery storage projects across multiple U.S. power markets.
|
|
|
Recent News
|
RedChip TV
|
|
|
|
RedChip Highlights BNB Plus Corp. (NASDAQ: BNBX) & Obook Holdings Inc. (NASDAQ: OWLS)
|
|
|
|
|
|
|
|
|
|
From Healthcare SaaS to Nuclear Renaissance: Latest Additions to the RedChip Nation
RedChip is pleased to welcome Comprehensive Healthcare Systems (OTCQB: CMHSF | TSXV: CHS) and Foremost Clean Energy (Nasdaq: FMST | CSE: FAT) to the RedChip Nation.
Comprehensive Healthcare Systems (OTCQB: CMHSF | TSXV: CHS)
Comprehensive Healthcare is a high-margin SaaS provider serving the $4–6B U.S. healthcare benefits administration market. With its proprietary Novus 360 platform, CMHSF enables over 1 million members annually to access streamlined, automated healthcare and retirement benefits. Backed by 95%+ retention and over C$35M in signed contracts, the company is poised for breakout growth as it targets $100M in total contracts by 2028.
Foremost Clean Energy (NASDAQ: FMST | CSE: FAT)
Foremost is one of the only Nasdaq-listed uranium explorers — and it’s not wasting the opportunity. With strategic partnerships, including Denison Mines as its largest shareholder, Foremost controls 10 highly prospective uranium properties in Canada’s world-class Athabasca Basin. Its diversified portfolio also includes lithium and gold projects, positioning the company at the forefront of the clean energy transition.
|
|
|
Unlock Smarter Investing with RedChat
|
|
|
Tired of sifting through endless filings? Let RedChat do the heavy lifting. Get real-time, data-driven insights on over 2,000 small-cap stocks—instantly. Save time, make informed decisions, and stay ahead of the market.
|
|
Access RedChat now, free of charge.
|
|
|
|
|
Recent Research Coverage Updates

| Company |
Rating |
Price Target |
Firm |
Report Date |
| Enlivex Therapeutics (Nasdaq: ENLV) |
Buy |
$13 |
HC Wainwright |
January 13, 2026 |
| NioCorp Developments (Nasdaq: NB) |
Buy |
$8.7 |
Freedom Capital Markets |
January 7, 2026 |
| Gorilla Technology (Nasdaq: GRRR) |
Buy |
$31 |
Cantor Fitzgerald |
December 11, 2025 |
| NioCorp Developments (Nasdaq: NB) |
Outperform |
$12 |
William Blair |
November 20, 2025 |
| Alliance Entertainment (Nasdaq: AENT) |
Buy |
$11 |
Noble Capital |
November 14, 2025 |
| Alliance Entertainment (Nasdaq: AENT) |
Buy |
$10 |
Maxim |
November 13, 2025 |
| Connect Biopharma (Nasdaq: CNTB) |
Buy |
$10 |
BTIG |
November 12, 2025 |
| Nova Minerals (Nasdaq: NVA) |
Buy |
$50 |
ThinkEquity |
October 27, 2025 |
| NioCorp (Nasdaq: NB) |
Buy |
$15 |
Maxim |
October 15, 2025 |
| NioCorp (Nasdaq: NB) |
Buy |
$8 |
H.C. Wainwright |
September 22, 2025 |
| Alliance Entertainment (Nasdaq: AENT) |
Buy |
$11 |
Noble Capital |
October 6, 2025 |
| FibroBiologics (Nasdaq: FBLG) |
Buy |
$4 |
Maxim |
September 22, 2025 |
| XORTX Therapeutics (Nasdaq: XRTX) |
Buy |
$14 |
AGP |
September 18, 2025 |
| FibroBiologics (Nasdaq: FBLG) |
Buy |
$10 |
H.C. Wainwright |
September 12, 2025 |
| Alliance Entertainment (Nasdaq: AENT) |
Buy |
$10 |
Maxim |
September 11, 2025 |
| FibroBiologics (Nasdaq: FBLG) |
Buy |
$16 |
D Boral |
September 10, 2025 |
| Greenwich LifeSciences (Nasdaq: GLSI) |
Buy |
$45 |
Noble |
August 20, 2025 |
| Nexalin Technology (Nasdaq: NXL) |
Buy |
$4 |
Maxim |
August 19, 2025 |
| Atossa Therapeutics (Nasdaq: ATOS) |
Buy |
$7 |
HC Waingwright |
August 12, 2025 |
| Atossa Therapeutics (Nasdaq: ATOS) |
Buy |
$4 |
Maxim |
August 12, 2025 |
| Atossa Therapeutics (Nasdaq: ATOS) |
Buy |
$4 |
Maxim |
August 12, 2025 |
|

|
|
|
|
|
Small Stocks, Big Money™ Podcast
|
|
The podcast features in-depth interviews with CEO's from the top names in small-cap stocks, providing listeners with a unique perspective not found anywhere else.
|
|
Available on:
|
|
|
|
|
|
|
Upcoming Events
|
|
|
Nexalin Technology (NASDAQ: NXL)
4:15pm Eastern
Nexalin designs and develops innovative neurostimulation products to uniquely help combat the ongoing global mental health epidemic.
|
|
|
|
Bimergen Energy (OTCQB: BESS)
4:15pm Eastern
Bimergen Energy Corporation is a publicly traded independent power provider and project developer focused on utility-scale battery energy storage systems (BESS) assets.
|
|
|
|
Archived Events
|
|
|
Fintech & DATS Virtual Investor Conference
4:15pm Eastern
The evolution of financial technology is reshaping how money moves, how value is stored, and how institutions manage digital assets. From modern payment infrastructure and embedded finance to secure custody, tokenization, and enterprise-grade digital asset management, fintech innovation is creating some of the most compelling investment opportunities in today’s markets.
|
|
|
|
ProPhase Labs (OTC: PRPH)
4:15pm Eastern
ProPhase Labs Inc. (OTC: PRPH) (“ProPhase”) is a next-generation biotech, genomics and consumer products company. Our mission is to build a healthier world through bold innovation and actionable insight.
|
|
|
|
Quote of the Week
|
" An investment in knowledge pays the best interest "
|
|
|
|
|
Order "Small Stocks, Big Money™ Today!
Dave Gentry's new book, Small Stocks, Big Money: Interviews With Microcap Superstars, is now available for pre-order. Published by Wiley Finance, this first-hand perspective and insider information on the fast world of microcap investing is now available for purchase.
|
|
|
|
|
|
|
Lesson of the Week
Dollar cost averaging is one way to combat the volatility in small-caps.
|
|
|
|
|
|
|